High Anticholinergic Burden and Dental Caries: Findings from Northern Finland Birth Cohort 1966

Overview

Journal JDR Clin Trans Res

Publisher Sage Publications

Specialty Dentistry

Date 2024 Jun 14

PMID 38872382

Authors

A Tiisanoja

V Anttonen

A-M Syrjala

P Ylostalo

Affiliations

Soon will be listed here.

Abstract

Introduction: Anticholinergic drugs propose a threat for oral health by causing dry mouth. The aim of this cross-sectional study was to investigate whether a high anticholinergic burden was associated with the presence of initial caries lesions, manifested caries lesions, dental fillings, or tooth loss among 46-y-old people.

Methods: The study population consisted of 1,906 participants from the Northern Finland Birth Cohort 1966 who underwent an oral health examination in 2012-2013. Socioeconomic and medical data were collected from questionnaires, medical records, and national registers. Nine previously published anticholinergic scales were combined and used to measure the high anticholinergic burden from the participants' medication data. Cariological status was determined according to the International Caries Detection and Assessment System, and the number of missing teeth (excluding third molars) was used as an indicator for tooth loss. The decayed, missing, and filled surfaces index was used to depict caries experience. Negative binominal regression models were used to estimate prevalence rate ratios (PRRs) and confidence intervals (CIs).

Results: Fourteen percent of the participants ( = 276) used at least 1 anticholinergic drug and about 3% had a high anticholinergic burden ( = 61). After adjusting for confounding factors, participants with a high anticholinergic burden had a higher likelihood of having manifested carious lesions needing restorative treatment (PRR, 1.60; CI, 1.11-2.29) and more missing teeth (PRR, 1.59; CI, 1.13-2.24) when compared to participants without any or with a lower anticholinergic burden.

Conclusions: High anticholinergic burden was associated with a present caries experience and with tooth loss among the general middle-aged population.

Knowledge Transfer Statement: The findings of this study suggest that middle-aged patients with a high anticholinergic burden may have a heightened risk of dental caries. These patients may benefit from targeted caries preventive regimes.

References

Rindal D, Rush W, Peters D, Maupome G . Antidepressant xerogenic medications and restoration rates. Community Dent Oral Epidemiol. 2005; 33(1):74-80. DOI: 10.1111/j.1600-0528.2004.00201.x. View

Salahudeen M, Duffull S, Nishtala P . Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015; 15:31. PMC: 4377853. DOI: 10.1186/s12877-015-0029-9. View

Carnahan R, Lund B, Perry P, Pollock B, Culp K . The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006; 46(12):1481-6. DOI: 10.1177/0091270006292126. View

Jurasic M, Gibson G, Wehler C, Orner M, Jones J . Caries prevalence and associations with medications and medical comorbidities. J Public Health Dent. 2018; 79(1):34-43. DOI: 10.1111/jphd.12292. View

Rudolph J, Salow M, Angelini M, McGlinchey R . The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008; 168(5):508-13. DOI: 10.1001/archinternmed.2007.106. View

Tiisanoja A, Syrjala A, Anttonen V, Ylostalo P . Anticholinergic burden, oral hygiene practices, and oral hygiene status-cross-sectional findings from the Northern Finland Birth Cohort 1966. Clin Oral Investig. 2020; 25(4):1829-1837. PMC: 7966223. DOI: 10.1007/s00784-020-03485-0. View

Janket S, Jones J, Rich S, Meurman J, Garcia R, Miller D . Xerostomic medications and oral health: the Veterans Dental Study (part I). Gerodontology. 2003; 20(1):41-9. DOI: 10.1111/j.1741-2358.2003.00041.x. View

Mindell J, Giampaoli S, Goesswald A, Kamtsiuris P, Mann C, Mannisto S . Sample selection, recruitment and participation rates in health examination surveys in Europe--experience from seven national surveys. BMC Med Res Methodol. 2015; 15:78. PMC: 4595185. DOI: 10.1186/s12874-015-0072-4. View

Hu K, Chou Y, Wen Y, Hsieh K, Tsai J, Yang P . Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study. Psychiatry Res. 2016; 245:45-50. DOI: 10.1016/j.psychres.2016.07.047. View

10.

Lexomboon D, Tan E, Hoijer J, Garcia-Ptacek S, Eriksdotter M, Religa D . The Effect of Xerostomic Medication on Oral Health in Persons With Dementia. J Am Med Dir Assoc. 2018; 19(12):1080-1085.e2. DOI: 10.1016/j.jamda.2018.05.014. View

11.

Han L, Agostini J, Allore H . Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008; 56(12):2203-10. PMC: 3952110. DOI: 10.1111/j.1532-5415.2008.02009.x. View

12.

Janssens B, Petrovic M, Jacquet W, Schols J, Vanobbergen J, De Visschere L . Medication Use and Its Potential Impact on the Oral Health Status of Nursing Home Residents in Flanders (Belgium). J Am Med Dir Assoc. 2017; 18(9):809.e1-809.e8. DOI: 10.1016/j.jamda.2017.06.003. View

13.

Chew M, Mulsant B, Pollock B, Lehman M, Greenspan A, Mahmoud R . Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008; 56(7):1333-41. DOI: 10.1111/j.1532-5415.2008.01737.x. View

14.

Thomson W, John Spencer A, Slade G, Chalmers J . Is medication a risk factor for dental caries among older people?. Community Dent Oral Epidemiol. 2002; 30(3):224-32. DOI: 10.1034/j.1600-0528.2002.300309.x. View

15.

Sittironnarit G, Ames D, Bush A, Faux N, Flicker L, Foster J . Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord. 2011; 31(3):173-8. DOI: 10.1159/000325171. View

16.

Wolff A, Kumar Joshi R, Ekstrom J, Aframian D, Pedersen A, Proctor G . A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2016; 17(1):1-28. PMC: 5318321. DOI: 10.1007/s40268-016-0153-9. View

17.

Tegelberg P, Tervonen T, Knuuttila M, Jokelainen J, Keinanen-Kiukaanniemi S, Auvinen J . Long-term metabolic syndrome is associated with periodontal pockets and alveolar bone loss. J Clin Periodontol. 2019; 46(8):799-808. DOI: 10.1111/jcpe.13154. View

18.

Laajala A, Pesonen P, Anttonen V, Laitala M . Association of Enamel Caries Lesions with Oral Hygiene and DMFT among Adults. Caries Res. 2019; 53(4):475-481. DOI: 10.1159/000497358. View

19.

Ismail A, Sohn W, Tellez M, Amaya A, Sen A, Hasson H . The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol. 2007; 35(3):170-8. DOI: 10.1111/j.1600-0528.2007.00347.x. View

20.

Ehrt U, Broich K, Larsen J, Ballard C, Aarsland D . Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry. 2009; 81(2):160-5. DOI: 10.1136/jnnp.2009.186239. View